SALONPAS

This brand name is authorized in Brazil, Hong Kong SAR China, Nigeria.

Active ingredients

The drug SALONPAS contains a combination of these active pharmaceutical ingredients (APIs):

1	Methyl salicylate UNII LAV5U5022Y - METHYL SALICYLATE
	Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.
	Read more about Methyl salicylate
2	l-Menthol UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
	Read more about Menthol
3	dl-Camphor UNII 213N3S8275 - CAMPHOR, (-)-
	Read more about Camphora
4	Tocopheryl acetate UNII H4N855PNZ1 - .ALPHA.-TOCOPHEROL
	Vitamin E is known to exert an important physiological function as an antioxidant for fats, with a sparing action on vitamin A, carotenoids and on unsaturated fatty acids. Other work has demonstrated that vitamin E is connected with the maintenance of certain factors essential for the normal metabolic cycle.
	Read more about Vitamin E

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AC	Preparations with salicylic acid derivatives	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	511700101176417, 511700102172415, 511700201170410, 511700205176413
HK	Department of Health Drug Office	50034
NG	Registered Drug Product Database	A4-100511
Switch country to Nigeria in order to find specific presentations of SALONPAS